Americord Registry Announces Andrew Horne as Advisory Board Member
Andrew Horne Joins Advisory Board of Fast-Growing Cord Blood Bank
NEW YORK, June 30, 2015 /PRNewswire/ -- Today, Americord Registry, one of the fastest growing cord blood banks in the U.S., announced Andrew Horne, a partner at Kirkland & Ellis LLP, as the newest member of its Advisory Board.
Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO
"We are thrilled about Andrew Horne's appointment to Americord's Advisory Board," says Martin Smithmyer, CEO of Americord. "He brings a wealth of knowledge and experience in his legal career that will assist Americord's growth and vision."
Andrew Horne is a litigation partner at Kirkland & Ellis LLP and has over 15 years of experience both practicing and studying law. He holds degrees from Harvard Law School (LL.M.), Glasgow Graduate School of Law (Dip. L.P.) and University of Strathclyde (LL.B.). He has represented companies in an array of fields including technology, pharmaceutical, telecommunications, biotech, insurance, defense and entertainment industries.
"Mr. Horne's experience in broad commercial litigation processes for public and private companies, including Fortune 50 companies, brings new perspective and insight to Americord's initiatives and direction," says Smithmyer. "He has particular experience in the biotech sphere and we're excited about what he'll bring to the growing industry of cord blood banking."
Prior to joining Kirkland & Ellis, Mr. Horne taught international private law and torte law at the University of Strathclyde in Glasgow, Scotland. He is currently an Associate Fellow at the Society for Advanced Legal Studies and was a John F. Kennedy Memorial Scholar at Harvard Law School.
About Americord Registry
Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company's laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord Registry's website at www.americordblood.com for more information.
PRESS CONTACT:
Raechel Sherwood
[email protected]
866-503-6005 ext. 944
SOURCE Americord Registry
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article